[Interview booklet] Achieving cardiac regenerative medicine through rapid protein measurement
Rapid measurement of secreted protein levels derived from iPS cells! Towards the realization of cardiac regenerative medicine.
In Japan, where transplant treatments are not progressing, the realization of regenerative medicine using human ES cells and iPS cells is eagerly awaited. To achieve this, the key is to efficiently and cost-effectively remove undifferentiated cells that pose a risk of tumor formation and to recover a large quantity of purified cells. Professor Shugo Toyama and his team at Fujita Medical University Tokyo Advanced Medical Research Center successfully transplanted cardiac tissue balls created from human iPS cells into cynomolgus monkeys that had suffered myocardial infarction, leading to heart regeneration. We asked Professor Toyama about the motivation behind his research and the results achieved. Excerpt from the interview article: "Protein analysis is usually evaluated using ELISA, which takes a considerable amount of time, so we only measured it for important samples. However, with this fully automated immunoassay device, we can now obtain data very conveniently and quickly, which has greatly benefited our research along with the quality assessment of miRNA." *The full text can be accessed by downloading the user interview article via the "Download Catalog" button. For more details, please feel free to contact us.
Inquire About This Product
basic information
Please contact us.
Price range
Delivery Time
Applications/Examples of results
*You can view the detailed content of the article through the related link. For more information, please feel free to contact us.*
catalog(4)
Download All Catalogs![[Interview booklet] Quality control of cell manufacturing without human intervention through mechanization.](https://image.mono.ipros.com/public/catalog/image/01/b20/796125/IPROS5393216478718667743.jpeg?w=120&h=170)
![[Interview booklet] What measurement devices accelerated research in regenerative medicine technology?](https://image.mono.ipros.com/public/catalog/image/01/750/783646/IPROS3921757335968201992.jpeg?w=120&h=170)
Company information
Since its establishment in 1968, our company has been engaged in the field of specimen testing, focusing on the analysis of samples such as blood and urine, and currently supports the health of people in over 190 countries and regions. In the field of specimen testing, we have achieved a top-class market share in three areas: "Hematology," "Coagulation Testing," and "Urinalysis." We contribute to improving the quality of life (QOL) of people around the world in various scenes of their lifelong healthcare journey, and we aim to realize a rich health society through the optimization of medical care and healthcare costs.